13F manager/RXRX/

Cathie Wood (ARK Invest) exit Recursion Pharmaceuticals, Inc.

Cathie Wood (ARK Invest) exit $211.1M of disclosed value in Recursion Pharmaceuticals, Inc..

Signal
Investor Move
Action
Exit
Capital
$211.1M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence